MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0058373
Molecular Products Group India Private Limited - travel and hospitality in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹86.25 Lakh
▼ 8% YoY
Net profit · FY 2025
₹9.66 Lakh
Net margin 11.2%
EBITDA · FY 2025
₹9.34 Lakh
EBITDA margin 10.8%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹39.5 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings
Active GSTINs
1
of 3 registered
About Molecular Products Group India Private Limited
Data last updated:
Molecular Products Group India Private Limited is a foreign private limited company based in Thane, Maharashtra, India, a subsidiary of Molecular Products Group Limited. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 12 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2016FTC271967. Its GSTIN is 27AAKCM1170E1ZN (Maharashtra). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹39.5 Lakh. It is led by directors including Jan Willem Radstaak and Brandon Christopher Smith.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 72, H T Industrial Complex Thane (W), Maharashtra, India – 400604.
As per the financials filed for FY 2025, the company reported a revenue of ₹86.25 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹9.66 Lakh (net margin 11.2%) and EBITDA of ₹9.34 Lakh (EBITDA margin 10.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
Molecular Products Group India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0058373). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website molecularproducts.com.
Company details
CIN U74120MH2016FTC271967
Registration Number 271967
Incorporation Date 12 January 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Molecular Products Group Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0058373
Key People
Jan Willem Radstaak Director Brandon Christopher Smith Director Kelly Anne Reinke Director Recognitions & Rankings of Molecular Products Group India
Contact details
Molecular Products Group India Private Limited's registered office is in Thane, Maharashtra. Its website is molecularproducts.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 72, H T Industrial Complex Thane (W), Maharashtra, India – 400604
- IndustryTravel and Hospitality, Consumer Professional Services
To see the full contact details of Molecular Products Group India Private Limited, buy the company report.
Comprehensive company report
Molecular Products Group India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Molecular Products Group India is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Administrative and support service activities | 82 | Office administrative, office support and other business support activities |
To see the full business activity and turnover split of Molecular Products Group India Private Limited, buy the company report.
Financials of Molecular Products Group India Private Limited
FY 2025 filings availableMolecular Products Group India Private Limited reported revenue of ₹86.25 Lakh (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹86.25 Lakh ▼ 8%
Net profit · FY 2025
₹9.66 Lakh margin 11.2%
EBITDA · FY 2025
₹9.34 Lakh margin 10.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 2%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 52%
5 years · compounded
▲ 83%
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.8% | ||||
| Net Profit Margin | 11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Molecular Products Group India Private Limited, buy the company report.
Board of directors of Molecular Products Group India Private Limited
Molecular Products Group India has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jan Willem Radstaak Also directs: Purafil Solutions India Private Limited, Clear Edge Filtration India Private Limited, Clear Edge Exports Private Limited and 1 more | Director | 03 Jun 2021 | 5 Years 5 Months | Current |
| Brandon Christopher Smith | Director | 26 May 2023 | 3 Years 5 Months | Current |
| Kelly Anne Reinke | Director | 26 May 2023 | 3 Years 5 Months | Current |
| Vikrant Bapusaheb Patil Also directs: Basp Life Sciences Private Limited | Director | 12 Jan 2016 | 10 Years 9 Months | Current |
Auditor
Molecular Products Group India Private Limited is audited by P B N A & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P B N A & ASSOCIATES | FY 2020 | 031245N |
Shareholding
The shareholding of Molecular Products Group India Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Molecular Products Group India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Molecular Products Group India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Molecular Products Group India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Molecular Products Group India has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCM1170E1ZN | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Molecular Products Group India Private Limited, buy the company report.
Recent activity
Molecular Products Group India Private Limited has 11 board changes on record since 2016: 4 appointments and 7 cessations. The latest: Brandon Christopher Smith was appointed as Director on 26 May 2023.
AGM
Molecular Products Group India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Molecular Products Group India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Brandon Christopher Smith was appointed as Director.
Appointed
Kelly Anne Reinke was appointed as Director.
Ceased
Jan Willem Radstaak ceased to be Additional Director.
Ceased
John Troy Rhudy ceased to be Additional Director.
Ceased
Joseph Manuel Carloto ceased to be Additional Director.
Appointed
Jan Willem Radstaak was appointed as Director.
Ceased
Peter Michael Manos ceased to be Director.
Ceased
Christopher Neil Stallmann ceased to be Director.
Ceased
Andrew Clark Mckernan ceased to be Director.
Ceased
Ian William Mckernan ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Molecular Products Group India is an active foreign private limited company based in Thane, Maharashtra, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 12 January 2016 (10+ years old) and is registered under CIN U74120MH2016FTC271967.
Molecular Products Group India has 4 current directors:
- Jan Willem Radstaak - Director
- Brandon Christopher Smith - Director
- Kelly Anne Reinke - Director
- Vikrant Bapusaheb Patil - Director
The latest financial statements of Molecular Products Group India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Molecular Products Group India is 27AAKCM1170E1ZN, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Molecular Products Group India is U74120MH2016FTC271967. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Molecular Products Group India was incorporated on 12 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Brandon Christopher Smith was appointed as Director on 26 May 2023. Kelly Anne Reinke was appointed as Director on 26 May 2023. Jan Willem Radstaak ceased to be Additional Director on 30 Nov 2021. Molecular Products Group India has 11 board changes on record in total.
Yes, Molecular Products Group India is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0058373).
Molecular Products Group India can be reached through the website molecularproducts.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Molecular Products Group India is at Plot No – 72, H T Industrial Complex Thane W, Maharashtra, India – 400604.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages